14 , 15 , 25 , 26 , 27 , 28 A clinical trial in patients with obesity and T2DM has reported that treatment of LY2405319, a variant of fibroblast growth factor 21, produced improvements in dyslipidemia, favorable effects on body weight, fasting insulin, and adiponectin, and a significant trend toward glucose lowering. 15 In the current study, the significant temporality parameters of the path from LVMI/LVH to glucose/T2DM provided additional evidence to support the view that the link between initial LVH and the development of T2DM is mediated through the heart‐derived hormones.
← all excerpts
Relationship Between Left Ventricular Hypertrophy and Diabetes Is Likely Bidirectional: A Temporality Analysis.
1
—
—